Elon Musk is betting that the next phase of his sprawling technology empire will require a building on a scale that has never existed before. SpaceX and Tesla are building Terafab, a 100-million-square-foot semiconductor manufacturing facility in Grimes County, Texas, more than five times the size of the world’s largest building. “Terafab Texas will be the
Situational Awareness may have had to sell off the majority of its public portfolio last month, but the AI-focused hedge fund is still making some big bets. This week, the fund invested $400 million into Source Foundry, a startup founded by Stanford researchers aiming to make chip manufacturing faster and cheaper, according to The Wall
US President Donald Trump signed an executive order on Thursday that imposes a 15% tariff on imported products made from polysilicon, a crucial material used in semiconductors and solar panels. The order also set minimum import prices on polysilicon and related products. It comes after a national security investigation into the production of the material
Residents of a rural Texas county say they want more control over the gigantic AI infrastructure projects sprouting in their backyards. Nearly 900 residents of Grimes County, the site of Elon Musk’s planned 100-million-square-foot Terafab semiconductor factory, signed a petition calling for more stringent regulations on large infrastructure projects that receive public incentives. The residents
AMD says it has a major advantage in the AI chip race against Nvidia: being more open. AMD has long promoted this strategy through its open-source ROCm software, used to program AI chips. Since ROCm is available as open source, it’s free for anyone to use, download, or modify. On the company’s earnings call on
Science Corporation, a startup developing new brain-computer interfaces (BCIs), has won approval from Europe’s medical device regulator to begin selling a device that restores vision lost due to age-related macular degeneration. The company said the device, called PRIMA, also received a designation from the U.S. Food and Drug Administration, which is the first step toward